Clinical Trials

Showing trials with last updates posted in 2024.

NCT03648489 | COMPLETED | PHASE2
134 participants

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Study Type:
INTERVENTIONAL
Last Updated:
2024-09-20
Start Date:
2018-09-21
Completion:
2023-11-30
Conditions
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Ovarian Carcinosarcoma
  • Ovarian Serous Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Clear Cell Adenocarcinoma
  • Fallopian Tube Cancer
  • Fallopian Tube Neoplasms
  • Primary Peritoneal Carcinoma
  • Primary Peritoneal Serous Adenocarcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page